Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Prevalence and associated factors of seizures and epilepsy in children with congenital heart disease: a systematic review and meta-analysis

Abstract

BackgroundChildren with congenital heart disease (CHD) are vulnerable to acute symptomatic seizures and long-term epilepsy, but reported estimates vary across settings and outcome definitions.MethodsPubMed/MEDLINE, Embase, Cochrane CENTRAL, and Web of Science were searched from inception until 3 June 2026. Observational studies reporting seizures or epilepsy in children with CHD were eligible. Random-effects models separately pooled logit-transformed prevalence estimates for long-term epilepsy and acute or early/in-hospital seizures. Odds ratios (ORs), mean differences (MDs), and standardized mean differences (SMDs) were pooled for associated factors. Risk of bias was appraised utilizing the Newcastle–Ottawa Scale (NOS).ResultsTen studies were included, of which nine contributed binary prevalence data. Six studies comprising 50,563 participants and 1,228 cases were included in the primary analysis of long-term epilepsy. The pooled prevalence was 3.1% (95% CI, 2.2%−4.2%; I2 = 75.3%). Three studies comprising 418,193 participants and 7,465 cases yielded a descriptive pooled estimate of 7.5% for acute or early/in-hospital seizures (95% CI, 1.4%−31.2%; I2 = 99.4%), with limited generalizability across CHD populations. Factors associated with higher odds of seizures or epilepsy included neurological complications, extracorporeal membrane oxygenation (ECMO) use, single-ventricle physiology, delayed sternal closure, repeated cardiac surgery, and prematurity.ConclusionsThe available evidence suggests that children with CHD may experience clinically important burdens of acute seizures and long-term epilepsy. The observed associations may inform future studies of targeted neurological surveillance, but do not establish causal effects or surveillance benefits.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261397297, identifier: CRD420261397297.

Related

  1. Beyond Primary Epilepsy: Fahr's Syndrome Secondary to Congenital Parathyroid Agenesis Presenting With Generalised Seizures in a Young Adult
    Maheen Bhangwar Baloch, Asim Ahmad, Hammad Buksh Ilahi
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Intraspinal abnormalities in MRI-evaluated congenital scoliosis: a systematic review and meta-analysis of prevalence, geographic variation, vertebral anomaly patterns, and Cobb angle.
    Nizar Algarni, Khalid Alrasheed, Faisal Alkhunein +3
    North American Spine Society journalPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. How Focal Seizures Impair Consciousness: Clinical Features and Network Mechanisms in Temporal Lobe Epilepsy
    Zhiwen Zhou, Atsushi Kasai
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textPsychiatry & mental healthJ-STAGE
  4. Biofluid Biomarkers of Neuronal and Glial Injury in Epilepsy and Seizures: A Comprehensive Review
    Valentin Moroșanu, Smaranda Maier, Iulian Roman-Filip +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossrefEurope PMC
  5. Medically refractory epilepsy comorbid with psychogenic non-epileptic seizures and intellectual disability in a patient with balanced t(14;X) translocation: a case report
    Henry Y. Feng, Ping Li
    Journal of Medical Case ReportsPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
BibTeX
@article{li2026prevalence,
  title = {{Prevalence and associated factors of seizures and epilepsy in children with congenital heart disease: a systematic review and meta-analysis}},
  author = {Hongyu Li and Yupeng Lei},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = nov,
  doi = {10.3389/fpubh.2026.1955892},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1955892},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Prevalence and associated factors of seizures and epilepsy in children with congenital heart disease: a systematic review and meta-analysis
AU  - Hongyu Li
AU  - Yupeng Lei
PY  - 2026
DA  - 2026/11/10
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1955892
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1955892
AB  - BackgroundChildren with congenital heart disease (CHD) are vulnerable to acute symptomatic seizures and long-term epilepsy, but reported estimates vary across settings and outcome definitions.MethodsPubMed/MEDLINE, Embase, Cochrane CENTRAL, and Web of Science were searched from inception until 3 June 2026. Observational studies reporting seizures or epilepsy in children with CHD were eligible. Random-effects models separately pooled logit-transformed prevalence estimates for long-term epilepsy and acute or early/in-hospital seizures. Odds ratios (ORs), mean differences (MDs), and standardized mean differences (SMDs) were pooled for associated factors. Risk of bias was appraised utilizing the Newcastle–Ottawa Scale (NOS).ResultsTen studies were included, of which nine contributed binary prevalence data. Six studies comprising 50,563 participants and 1,228 cases were included in the primary analysis of long-term epilepsy. The pooled prevalence was 3.1% (95% CI, 2.2%−4.2%; I2 = 75.3%). Three studies comprising 418,193 participants and 7,465 cases yielded a descriptive pooled estimate of 7.5% for acute or early/in-hospital seizures (95% CI, 1.4%−31.2%; I2 = 99.4%), with limited generalizability across CHD populations. Factors associated with higher odds of seizures or epilepsy included neurological complications, extracorporeal membrane oxygenation (ECMO) use, single-ventricle physiology, delayed sternal closure, repeated cardiac surgery, and prematurity.ConclusionsThe available evidence suggests that children with CHD may experience clinically important burdens of acute seizures and long-term epilepsy. The observed associations may inform future studies of targeted neurological surveillance, but do not establish causal effects or surveillance benefits.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261397297, identifier: CRD420261397297.
SN  - 2296-2565
ER  -